Yahoo
NasdaqCM - Delayed Quote USD

Aptevo Therapeutics Inc. (APVO)

1.3500 +0.0100 (+0.75%)
At close: November 2 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
3,114
Operating Expense
26,886
26,312
24,602
28,878
31,755
Operating Income
-26,886
-26,312
-24,602
-28,878
-28,641
Other Income Expense
478
345
472
10,228
35,655
Pretax Income
-26,408
-25,967
-24,130
-18,650
7,014
Net Income Common Stockholders
-28,076
-27,538
-24,130
-17,411
8,027
Diluted NI Available to Com Stockholders
-28,076
-27,538
-24,130
-17,411
8,027
Basic EPS
456.62
-87.27
-5.96k
-527.61k
729.73k
Diluted EPS
456.62
-87.27
-31.46k
-527.61k
729.73k
Basic Average Shares
891.9000
315.5350
4.0510
0.0330
0.0110
Diluted Average Shares
891.9000
315.5350
4.0510
0.0330
0.0110
Total Operating Income as Reported
-26,886
-26,312
-24,602
-28,878
-28,641
Total Expenses
26,886
26,312
24,602
28,878
31,755
Net Income from Continuing & Discontinued Operation
-26,408
-25,967
-24,130
-17,411
8,027
Normalized Income
-26,408
-25,967
-24,130
-28,300
7,014
EBIT
-26,886
-26,312
-24,602
-28,878
-28,641
EBITDA
-26,689
-26,072
-24,250
-28,311
-27,740
Reconciled Depreciation
197
240
352
567
901
Net Income from Continuing Operation Net Minority Interest
-26,408
-25,967
-24,130
-18,650
7,014
Total Unusual Items Excluding Goodwill
--
--
0
9,650
0
Total Unusual Items
--
--
0
9,650
0
Normalized EBITDA
-26,689
-26,072
-24,250
-37,961
-27,740
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/20/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: